Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to provide insight into the impact of the immunosuppressant drug
sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant
medication, ketamine.